Shelton Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $230K | Hold |
2,171
| – | – | 0.01% | 608 |
|
|
2025
Q1 | $270K | Sell |
2,171
-159
| -7% | -$19.7K | 0.01% | 517 |
|
|
2024
Q4 | $287K | Sell |
2,330
-171
| -7% | -$21.1K | 0.01% | 521 |
|
|
2024
Q3 | $279K | Hold |
2,501
| – | – | 0.01% | 539 |
|
|
2024
Q2 | $267K | Sell |
2,501
-158
| -6% | -$16.9K | 0.01% | 532 |
|
|
2024
Q1 | $320K | Sell |
2,659
-105
| -4% | -$12.6K | 0.01% | 487 |
|
|
2023
Q4 | $340K | Sell |
2,764
-218
| -7% | -$26.8K | 0.01% | 429 |
|
|
2023
Q3 | $386K | Sell |
2,982
-147
| -5% | -$19K | 0.01% | 361 |
|
|
2023
Q2 | $388K | Hold |
3,129
| – | – | 0.01% | 377 |
|
|
2023
Q1 | $458K | Hold |
3,129
| – | – | 0.02% | 311 |
|
|
2022
Q4 | $498K | Hold |
3,129
| – | – | 0.05% | 268 |
|
|
2022
Q3 | $417K | Hold |
3,129
| – | – | 0.02% | 341 |
|
|
2022
Q2 | $488K | Hold |
3,129
| – | – | 0.02% | 323 |
|
|
2022
Q1 | $487K | Hold |
3,129
| – | – | 0.02% | 356 |
|
|
2021
Q4 | $399K | Hold |
3,129
| – | – | 0.01% | 439 |
|
|
2021
Q3 | $407K | Hold |
3,129
| – | – | 0.02% | 421 |
|
|
2021
Q2 | $556K | Buy |
3,129
+203
| +7% | +$36.1K | 0.02% | 351 |
|
|
2021
Q1 | $481K | Hold |
2,926
| – | – | 0.02% | 395 |
|
|
2020
Q4 | $483K | Buy |
+2,926
| New | +$483K | 0.02% | 347 |
|